Biocryst Pharmaceuticals (BCRX) Free Cash Flow: 2010-2015
Historic Free Cash Flow for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2015 value amounting to -$18.9 million.
- Biocryst Pharmaceuticals' Free Cash Flow fell 35.25% to -$18.9 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$18.2 million, marking a year-over-year increase of 52.82%. This contributed to the annual value of -$53.1 million for FY2024, which is 45.39% up from last year.
- As of Q4 2015, Biocryst Pharmaceuticals' Free Cash Flow stood at -$18.9 million, which was down 47.43% from -$12.8 million recorded in Q3 2015.
- Biocryst Pharmaceuticals' Free Cash Flow's 5-year high stood at $17.7 million during Q2 2015, with a 5-year trough of -$18.9 million in Q4 2015.
- Moreover, its 3-year median value for Free Cash Flow was -$8.3 million (2013), whereas its average is -$7.0 million.
- In the last 5 years, Biocryst Pharmaceuticals' Free Cash Flow tumbled by 208.81% in 2014 and then surged by 349.63% in 2015.
- Biocryst Pharmaceuticals' Free Cash Flow (MRQ) stood at -$4.0 million in 2011, then tumbled by 76.36% to -$7.0 million in 2012, then skyrocketed by 35.70% to -$4.5 million in 2013, then tumbled by 208.81% to -$14.0 million in 2014, then crashed by 35.25% to -$18.9 million in 2015.
- Its Free Cash Flow stands at -$18.9 million for Q4 2015, versus -$12.8 million for Q3 2015 and $17.7 million for Q2 2015.